U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
162061162061A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809CompletedNo Results AvailableSmoking|Healthy SubjectsDrug: GSK598809https://ClinicalTrials.gov/show/NCT00437840
162062162062rEEG Guided Pharmacotherapy of Subjects With Depression Treatment FailureCompletedNo Results AvailableDepressive DisorderOther: Star*D algorithm|Other: rEEG-guided therapyhttps://ClinicalTrials.gov/show/NCT00437827
162063162063Effect of Ketamine (Ketalar) on Intracranial PressureRecruitingNo Results AvailableTraumatic Brain Injury|Intracranial HypertensionDrug: Ketamine, effect on intracranial pressurehttps://ClinicalTrials.gov/show/NCT00437814
162064162064The Effect of a Digital Photograph of the Patient in a CT Scan Examination on the Quality of Diagnosis by the RadiologistNot yet recruitingNo Results AvailableHealthyhttps://ClinicalTrials.gov/show/NCT00437788
162065162065ACEIs and ARBs Treatment in Diabetic Patients -Drug Interactions and Adverse Drug EffectsRecruitingNo Results AvailableDiabetes Mellitus Type 2https://ClinicalTrials.gov/show/NCT00437775
162066162066Effectiveness of Botulinum Toxin Injection in the Tennis Elbow TreatmentCompletedNo Results AvailableTennis ElbowDrug: Botulinum Toxin A Injection|Drug: Placebo injectionhttps://ClinicalTrials.gov/show/NCT00437762
162067162067A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung CancerTerminatedNo Results AvailableNon-Small Cell Lung CancerDrug: CBT-1|Other: Placebohttps://ClinicalTrials.gov/show/NCT00437749
162068162068A Phase I Dose Finding Study of APO010 in Patients With Solid TumorsCompletedNo Results AvailableCancerDrug: APO010https://ClinicalTrials.gov/show/NCT00437736
162069162069A Study of NeoRecormon in Patients With Chronic Kidney Disease.CompletedNo Results AvailableAnemiaDrug: epoetin beta [NeoRecormon]https://ClinicalTrials.gov/show/NCT00437723
162070162070Safety and Efficacy of Bone Marrow Cell Transplantation in Humans Myocardial InfarctionRecruitingNo Results AvailableAcute Myocardial InfarctionProcedure: cell therapy, bone marrow derived stem cellhttps://ClinicalTrials.gov/show/NCT00437710
162071162071Thromboprophylaxis in Critically Ill PatientsTerminatedNo Results AvailableVenous ThromboembolismDrug: dalteparinhttps://ClinicalTrials.gov/show/NCT00437697
162072162072Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) TherapyRecruitingNo Results AvailableHIV Infections|Hepatitis CDrug: LPV/r|Drug: PEG-IFNa 2a|Drug: Ribavirin|Drug: NUCShttps://ClinicalTrials.gov/show/NCT00437684
162073162073Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective LevelsTerminatedNo Results AvailableTetanusDrug: Tetanus Immune Globulin (Human)|Biological: Diphtheria-Tetanus Toxoids Adsorbedhttps://ClinicalTrials.gov/show/NCT00437671
162074162074Safety and Efficacy Study of NBI-56418 in EndometriosisCompletedNo Results AvailableEndometriosisDrug: NBI-56418|Drug: depo-subQ provera 104https://ClinicalTrials.gov/show/NCT00437658
162075162075Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential HypertensionCompletedHas ResultsEssential HypertensionDrug: Valsartan 160 mg capsules|Drug: Amlodipine 5 mg capsules|Drug: placebohttps://ClinicalTrials.gov/show/NCT00437645
162076162076Study To Investigate If Repeat Doses Of GSK598809 Are Safe And Well Tolerated And To Evaluate Blood Levels Of GSK598809CompletedNo Results AvailableSubstance Dependence|Compulsive BehaviorDrug: GSK598809/Placebohttps://ClinicalTrials.gov/show/NCT00437632
162077162077A Study of Sequential Treatment With Daivobet (Betamethasone Dipropionate Plus Calcipotriol) and Daivonex (Calcipotriol) in Patients With Psoriasis.CompletedNo Results AvailablePsoriasisDrug: calcipotriol hydrate [Daivonex]https://ClinicalTrials.gov/show/NCT00437619
162078162078A Study of the Pharmacokinetics/Pharmacodynamics of GK Activator (2) in Type 2 Diabetes Patients With Hepatic Impairment.TerminatedNo Results AvailableDiabetes Mellitus, Type 2Drug: GK Activator (2)|Drug: Ethanolhttps://ClinicalTrials.gov/show/NCT00437606
162079162079UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane BlueCompletedNo Results AvailableRetinal DiseasesProcedure: ppVE, MP, ICG|Procedure: ppVE, MP, MBhttps://ClinicalTrials.gov/show/NCT00437593
162080162080Impact of Probiotic Regimen on Vancomycin Resistant Enterococcus Intestinal CarriageRecruitingNo Results AvailableVancomycin Resistant Enterococcus Intestinal CarriageDrug: Lactobacillus casei rhamnosus (strain Lcr 35 LC)https://ClinicalTrials.gov/show/NCT00437580
162081162081Prebiotics in the Prevention of Necrotizing EnterocolitisRecruitingNo Results AvailableNecrotizing EnterocolitisDietary Supplement: Galacto-oligosaccharide (GOS)|Other: Placebohttps://ClinicalTrials.gov/show/NCT00437567
162082162082Phase III Study for Glimepiride + Metformin Hydrochloride (Amaryl M) Slow Release (SR)CompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Glimepiridehttps://ClinicalTrials.gov/show/NCT00437554
162083162083Housing, Insulation and Health StudyCompletedNo Results AvailableRespiratory Illness|AsthmaDevice: Insulation retrofitted into househttps://ClinicalTrials.gov/show/NCT00437541
162084162084Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder CapacityRecruitingNo Results AvailableOveractive Bladder|Urge Urinary Incontinence|Enuresis|Self Clean Intermittent Catheterizationhttps://ClinicalTrials.gov/show/NCT00437528
162085162085A Phase I Study of Ovarian Cancer Peptides Plus GM-CSF and Adjuvant With Ovarian, Tubal or Peritoneal CancerCompletedNo Results AvailableEpithelial Ovarian, Tubal or Peritoneal CancerBiological: tumor peptide vaccine|Biological: tumor peptide vaccinehttps://ClinicalTrials.gov/show/NCT00437502
162086162086A Clinical Trial Comparing The Efficacy And Safety Of 2 Different Initial Dose Prescriptions For Exubera.TerminatedHas ResultsDiabetes Mellitus, Type 2Drug: Inhaled Human Insulin (Exubera)|Drug: Inhaled Human Insulin (Exubera)https://ClinicalTrials.gov/show/NCT00437489
162087162087Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV TherapyRecruitingNo Results AvailableHIV Infections|Hepatitis CDrug: LPV/r|Drug: Nucleoside Reverse Transcriptase Inhibitors|Drug: PEG-IFNa 2a|Drug: Ribavirinhttps://ClinicalTrials.gov/show/NCT00437476
162088162088Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) InhibitorCompletedNo Results AvailableGlomerulonephritisDrug: Ramiprilhttps://ClinicalTrials.gov/show/NCT00437463
162089162089Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic AcidActive, not recruitingNo Results AvailableAnemia in Myelodysplastic SyndromesDrug: Epoetin/Atrahttps://ClinicalTrials.gov/show/NCT00437450
162090162090A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664)CompletedNo Results AvailableTumorsDrug: Brivanibhttps://ClinicalTrials.gov/show/NCT00437437

* Görseller ve İçerik tekif hakkına sahip olabilir